Startup and Venture Capital News for July 24, 2026: Record $510 Billion in Six Months, Capital Concentration in AI, Major Rounds, IPOs, and M&A — An Overview for Investors
The global venture market is entering the end of July 2026 in a state that defies easy characterization. Formally, it is the best half-year in the history of the industry: global venture investments reached a record $510 billion in the first half of 2026, surpassing the total for all of 2025 ($440 billion). However, behind this record number lies an unprecedented concentration: two companies — OpenAI and Anthropic — attracted $217 billion, or 43% of all venture capital globally. For venture investors and funds, this signifies not a “boom,” but a restructuring of the very logic of capital allocation.
The key thesis of the recent trading sessions and funding rounds is this: Investors are no longer paying for “exposure to AI” as such. They are paying for control over bottlenecks — for infrastructure, regulated workflows, production capabilities, and systems that cannot be replaced with a single API call. Deals announced this week showcase this logic with rare clarity.
Record Half-Year and the Price of Capital Concentration
The statistics for the first half of 2026 have rewritten all historical benchmarks in the venture market:
- $510 billion — global venture investments for H1 2026, compared to $375 billion in the peak half-year of 2021.
- $305 billion — the first quarter, the largest quarter in industry history.
- $205 billion — the second quarter, distributed among more than 5,000 startups.
- Over 70% of the capital in Q2 went to companies focused on artificial intelligence — up from less than 50% a year earlier.
- 53% of the volume in Q2 came from mega-rounds of $1 billion or more: 16 companies raised $108.6 billion.
For venture funds, this creates an uncomfortable arithmetic. A manager without allocation in OpenAI or Anthropic has objectively shown weak mid-year results — not because they misjudged their selection of portfolio companies, but because the market benchmark was formed by two capital tables. Late-stage funding rose 141% year-on-year in Q2: capital wasn’t expanding its reach; it was deepening positions in already proven winners.
Exits Are Back: A Record Quarter for IPOs and M&A
The most significant news for LPs is not the volume of investments but the restoration of liquidity. It is exits, not paper markups, that pay for the returns of fund vintages.
- 32 companies went public with a valuation of over $1 billion in Q2 2026.
- SpaceX's IPO on June 12 became the largest venture company offering in history: raising $75 billion at a valuation of $1.77 trillion, with shares closing up 19%.
- 24 companies were acquired at prices starting from $1 billion, with a total volume of $113 billion, a record high.
- SpaceX's acquisition of Anysphere (Cursor) for $60 billion — the largest startup acquisition in market history.
- Following SpaceX, the next largest offerings were from inference chip manufacturer Cerebras Systems and quantum company Quantinuum.
The multi-year logjam for exits has finally begun to dissipate. For late-stage investors, this fundamentally changes the risk calculus: private capital is once again converting into real liquidity rather than just headline valuations.
Cybersecurity: A Category with the Highest Conversion Rate of Conviction
Cybersecurity remains a sector where venture funds are willing to underwrite scale before revenue disclosure. Company Glow exited stealth mode with a Series A round of $180 million at a valuation of $1.2 billion. The syndicate included Sequoia Capital, Cyberstarts, Greenoaks, Redpoint Ventures, Index Ventures, Lux Capital, and Operator Collective.
Glow's thesis is simple and therefore compelling: the endpoint has become the primary attack surface in an era where employees launch AI agents, install developer tools in minutes, and introduce risk faster than security teams can respond. The company positions itself not just as another detection layer next to CrowdStrike, Microsoft, SentinelOne, and Palo Alto Networks but on a political and orchestration level, determining which software and agents are allowed into the perimeter.
In the same segment, StrongestLayer raised $4.1 million led by Inovia Capital, bringing its seed funding total to $9.3 million. The company is building mail protection based on reasoning about message intent rather than signatures and reputation bases — a response to the rise of BEC-type attacks that do not contain explicitly malicious payloads.
Defense Technology: Geopolitics as an Investment Thesis
The most politically charged deal of the week was the round for company Cathedral: $160 million at a valuation of $1.4 billion, co-led by Andreessen Horowitz and Sequoia Capital. The startup, founded by alumni of the Department of Government Efficiency, is developing AI systems for military cyber operations — both defensive and offensive — and is reportedly exploring the possibility of acquisitions or partnerships for dedicated computing power.
For venture investors, Cathedral illustrates three converging forces: national security software based on AI, the founders' direct connections to federal procurement circles, and capital’s conviction that geopolitical competition justifies aggressive underwriting. The downside is political risk: proximity to power expedites contracts but makes the company vulnerable to shifts in the political landscape.
Physical AI and Robotics: From Demonstrations to Product Unit Economics
Robotics has attracted $18.8 billion since the beginning of 2026 — already more than in all of 2025. A key shift is the nature of argumentation from founders: buyers are interested in throughput, uptime, and cost per unit rather than demonstrations.
- Humanoid (London) — $152 million Series A at a post-money valuation of $1.35 billion, led by Prime Movers Lab with participation from Schaeffler, Bosch, Fubon Financial Holding Venture Capital, and Aglaé Ventures. The total amount raised is $270 million. Partnerships with SAP, NVIDIA, Bosch, and Siemens, along with a commercial agreement with Schaeffler, are transitioning the project from prototyping to industrial deployment. The company positions this round as proof of Europe's ability to grow a globally competitive player in physical AI.
- Gritt — $26 million Series A led by Obvious Ventures with participation from Union Square Ventures and Active Impact Investment. The company automates the installation of solar power plants: a crew of eight traditionally installs about 800 panels a day compared to 3,000–4,000 using Gritt's systems. The contracted volume is 2.8 GW over the next 18 months.
- 1872 (Cincinnati) — $15 million seed round from The O.H.I.O. Fund. Founders are former SpaceX engineers building an autonomous factory for metal structures in partnership with Path Robotics.
Energy and Materials: Supply Chain Sovereignty as an Asset Class
Company Sila raised $300 million led by Atreides Management and Sutter Hill Ventures with participation from 8VC, Bessemer Venture Partners, Matrix Partners, and funds managed by T. Rowe Price. The total funding raised is approximately $1.6 billion. The proceeds will be used to expand the production of silicon-carbon anodes in Moses Lake, Washington.
The investment thesis here extends beyond the electric vehicle market: Sila sells its technology to drones, satellites, electronics, robotics, and AI systems simultaneously. Capital seeks “shovels and picks” that can address multiple demand curves—especially where data centers and defense procurement are driving up the demand for batteries.
Another noteworthy company is Bluecore Energy — pre-seed funding of approximately $10 million led by Slauson & Co. The company is developing small modular reactors with water cooling on floating barges and has already delivered the first barge with a test reactor to Long Beach port. The initial 10 MW system is designed to power the equivalent of 15,000 households or a large port. The AI appetite for electricity has become an independent engine driving the formation of startups.
Fintech: Fewer Deals, More Infrastructure
Global fintech funding has grown approximately 23% year-on-year in the first half of 2026 despite a more than 25% drop in the number of deals. Capital is concentrating in large infrastructure bets.
- Augustus — $180 million Series B at a valuation of $1 billion, led by Tiger Global with participation from Hummingbird and QED. The company is building a “Global Dollar Bank” — direct access for international fintechs and banks to dollar accounts and clearing rails via a federally chartered institution with conditional approval from OCC. The total capital raised amounts to $210 million.
- Cashea (Caracas) — $100 million disclosed in a single announcement: Series A of $40 million led by Spice Expeditions (March 2026) and Series B of $60 million led by FinSight Ventures (June 2026). More than 10 million consumer accounts, 40,000 stores, and over 100 million transactions. This case demonstrates that frontier geographies can secure funding if the company showcases density of local distribution and repayment discipline from borrowers.
Healthcare and Biotech: Capital Has Become Disciplined
Biotech financing has split into two distinctly recognizable segments. Late, clinically de-risked assets still attract oversubscribed rounds; early-stage projects are being financed only under very narrow, specific technical wedges.
- Crystalys Therapeutics — $130 million Series B led by Frazier Life Sciences with participation from Wellington Management, HBM Healthcare Investments, Soleus Capital, Cormorant Asset Management, Novo Holdings, and SR One. The total funding raised is $335 million. The funds will be used for Phase III trials and preparation for commercialization of the gout treatment drug dotinurad.
- Candid Health — $120 million Series D led by Sixth Street Growth with participation from Oak HC/FT, 8VC, and Y Combinator. The company automates the medical billing cycle — a segment that wastes approximately $280 billion annually in the U.S. healthcare system. The valuation has tripled compared to Series C, with a contracted annual revenue growth of 190% year-on-year and a net dollar retention of 180%.
- Tikva Allocell (Singapore) — $8 million Series A from Kantharos Capital aimed at submitting an IND application by year-end.
- Brenus Pharma (Lyon) — €11 million extension of Series A, totaling €38 million, with participation from Bpifrance, Sambrinvest, and Korea Omega Investment Corp.
- Immitra Bio (Zurich) — €2.58 million pre-seed led by Backbone Ventures and OCCIDENT for in-vivo genome editing development.
Second-Order AI Infrastructure: Orchestration Over Models
An emerging class of deals involves companies making existing AI infrastructure suitable for industrial use. Meshy raised nearly $400 million in Series B at a valuation of $1.5 billion — the largest disclosed round in the AI-3D segment; the company's products are utilized by teams within five of the world's ten largest tech corporations, and its ARR has grown approximately twelvefold year-on-year. SkyPilot exited stealth mode with $20 million in seed funding led by Lux Capital with participation from Amplify Partners, Coatue, and Foundation Capital: the company integrates fragmented computing resources — hyperscalers, neo-clouds, Kubernetes clusters, and various accelerators — into a single management layer.
British company CuspAI earlier this week closed Series B at $450 million with backing from Kleiner Perkins, NEA, Bezos Expeditions, the UK government, AMD Ventures, and Lux Capital, bringing its total fundraising to over $650 million. The focus is on AI for the discovery of new materials.
Implications for Venture Funds and Institutional Investors
Practical takeaways for capital managers as of late July 2026:
- Record volumes do not equal a broad market. With $510 billion in the half-year, 43% was attributed to two companies. When assessing portfolio returns, it is more accurate to use median rather than mean benchmarks.
- The quality of the syndicate has become a survival signal. The market rewards the presence of specialized lead investors capable of supporting the company in subsequent rounds — this impacts pricing as much as metrics.
- Security is determined by control, not technology. Production assets, regulatory licenses, embedded distribution, and operational data — these are what endure amidst model commoditization.
- The exit window is open, but selectively. The record IPOs and M&A of Q2 provide late investors with a rationale for exits; however, the public market is accepting companies that appear as infrastructure rather than as functions.
- Geography has yielded to categories. The share of the U.S. dropped from 83% in Q1 to two-thirds in Q2 — an early signal of capital redistribution towards Europe and Asia.
- Capital efficiency has returned to the agenda. Companies demonstrating growth with small teams and positive unit economics receive valuation premiums that were absent during the “growth at all costs” cycle.
Conclusion: The Market is Narrow but Open
The venture market at the end of July 2026 is neither overheated nor closed. It is narrow, strategic, and increasingly intolerant of abstractions. Large checks continue to be written — but are more frequently reserved for companies that resemble not experiments, but future infrastructure in specific segments of the economy. For venture investors and funds, the primary skill in the new cycle will be the ability to distinguish between a company owning a bottleneck and one selling a function on top of someone else's model. This distinction, rather than the growth rate of the AI industry, will define the returns of the 2026 vintages.
